Skip to content
value.today

Nextgen Pharma LLC

Total raised
$9 M
1 round on record
Latest round
$9 M
Dec 2020
First round on record
Dec 2020
Today
Private
No later event on record

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Nextgen Pharma LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$9 MNo. 1$2 to $10 million

Nextgen Pharma LLC: Raise no. 1, Dec 2020

Investors in this round

36 investors had bought by the notice of Dec 21, 2020: 36 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
$9,000,000
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Puerto Rico

People named in the notice

  • Carmen Serrano · Executive Officer, Director
  • Federico Hernandez · Executive Officer, Director
  • Julian Londono · Executive Officer, Director
  • Kevin McGrath · Executive Officer, Director
  • Robert Weakly · Executive Officer, Director
  • Steve Zellers · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Carmen Serrano, Member. Source: SEC Form D, newest notice filed Dec 21, 2020. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nextgen Pharma LLC had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Dec 2020).

    SEC Form D (revenue range) · Dec 2020

  • The industry group it chose in its notices: Other.

    SEC Form D · Dec 2020

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nextgen Pharma LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 36 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nextgen Pharma LLC
NameRoleNamed in
Carmen SerranoExecutive officerDec 2020
Federico HernandezExecutive officerDec 2020
Julian LondonoExecutive officerDec 2020
Kevin McGrathExecutive officerDec 2020
Robert WeaklyExecutive officerDec 2020
Steve ZellersExecutive officerDec 2020
Carmen SerranoDirectorDec 2020
Federico HernandezDirectorDec 2020
Julian LondonoDirectorDec 2020
Kevin McGrathDirectorDec 2020
Robert WeaklyDirectorDec 2020
Steve ZellersDirectorDec 2020